Aiello A, Mancuso ME, Leone S, Rossi L, Cioni L, Teruzzi C. Cost analysis of extended half-life recombinant factor IX products in the treatment of haemophilia B in Italy: an update. Grhta [Internet]. 2022 Jan. 19 [cited 2024 Nov. 22];9(1):9-13. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/2331